EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Freeze-Drying of mRNA-LNPs Vaccines: A Review

M D Faizul Hussain Khan iD, Floriane Baudin, Ayyappasamy Sudalaiyadum Perumal iD, Amine A Kamen iD

Vaccines · 12.08.2025 · 13 (8) · 853

DOI: 10.3390/vaccines13080853 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Vaccines, online erschienen am 12.08.2025. Verfasst von M D Faizul Hussain Khan und 3 weiteren Autor:innen. Beteiligte Einrichtung: Viral Vectors and Vaccines Bioprocessing Group, Department of Bioengineering, McGill University, Montreal, QC H2X 1Y4, Canada. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 92 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Sciences and Engineering Council of Canada (NSERC), Canada Research Chair, Natural Sciences and Engineering Research Council (NSERC).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The instability of mRNA vaccines presents significant challenges for their storage, transportation, and large-scale distribution, particularly in resource-limited countries. Recently, freeze-drying (lyophilization) has been considered as a promising approach for preserving mRNA vaccine efficacy. This formulation technique enhances the long-term stability of mRNA vaccines by converting them into a stable dry powder. The purpose of this review is to provide an overview of the current knowledge on the progress of freeze-drying techniques for mRNA vaccines, with emphasis on the associated challenges. This review highlights the factors influencing the stability of freeze-dried mRNA vaccines and provides a comprehensive overview of the formulation components, including excipients, buffers, and surfactants, as well as the process parameters and storage conditions that aim to improve stability and shelf-life. By providing these insights, this review supports the advancement of more robust, scalable, and efficient lyophilization protocols, ultimately addressing the stability limitations of mRNA vaccines and enhancing their global accessibility.

Schlagwörter

Stichwörter der Autor:innen

LNPsbioprocessingformulationsfreeze-dryinginstabilitylipid nanoparticleslyophilizationmRNA vaccinesmRNA-LNPsvaccine stability

Autor:innen und Institutionen

  • Viral Vectors and Vaccines Bioprocessing Group, Department of Bioengineering, McGill University, Montreal, QC H2X 1Y4, Canada.
  • Department of Bioengineering, McGill University, Montreal, QC H3A 0E9, Canada.

ORCID-Profile: M D Faizul Hussain Khan, Ayyappasamy Sudalaiyadum Perumal, Amine A Kamen

Förderung

  • National Sciences and Engineering Council of Canada (NSERC)
  • Canada Research Chair
  • Natural Sciences and Engineering Research Council (NSERC)
  • Canada Biomedical Research Fund, Tri-council Agency

Zitieren

APA

Khan, M. D. F. H., Baudin, F., Sudalaiyadum Perumal, A., & Kamen, A. A. (2025). Freeze-Drying of mRNA-LNPs Vaccines: A Review. Vaccines, 13(8), 853. https://doi.org/10.3390/vaccines13080853

Vancouver

Khan MDFH, Baudin F, Sudalaiyadum Perumal A, Kamen AA. Freeze-Drying of mRNA-LNPs Vaccines: A Review. Vaccines. 2025;13(8):853. doi:10.3390/vaccines13080853

BibTeX
@article{Khan2025,
  author = {Khan, M D Faizul Hussain and Baudin, Floriane and Sudalaiyadum Perumal, Ayyappasamy and Kamen, Amine A},
  title = {Freeze-Drying of mRNA-LNPs Vaccines: A Review},
  journal = {Vaccines},
  year = {2025},
  volume = {13},
  number = {8},
  pages = {853},
  doi = {10.3390/vaccines13080853}
}
Kostenlos starten →